NF-κB/STAT5/miR-155 Network Targets PU.1 in FLT3-ITD-driven Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2014.231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

SHIP1 Is Targeted by miR-155 in Acute Myeloid Leukemia

Oncology Reports
MedicineCancer ResearchOncology
2014English

Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells Through Increased McL-1 Proteasomal Degradation

Clinical Cancer Research
Cancer ResearchOncology
2017English

Wogonin as a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/miR-155/PU.1 Pathway

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Silvestrol Exhibits Significant in Vivo and in Vitro Antileukemic Activities and Inhibits FLT3 and miR-155 Expressions in Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Potent Co-Operation Between the NUP98-NSD1 Fusion and the FLT3-ITD Mutation in Acute Myeloid Leukemia Induction

Haematologica
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy